These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 16792941)

  • 1. [HIV infection in patients aged 50 years or older in the HAART era].
    Villamil-Cajoto I; Losada-Arias E; Prieto-Martínez A; Lires-Moledo C; Quintela-Vázquez P
    Enferm Infecc Microbiol Clin; 2006; 24(6):382-4. PubMed ID: 16792941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
    Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
    Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy].
    Reus S; Portilla J; Gimeno A; Sánchez-Payá J; García-Henarejos JA; Martínez-Madrid O; Usó J; Roca B; Galindo MJ; López-Aldeguer J
    Enferm Infecc Microbiol Clin; 2004 Mar; 22(3):142-9. PubMed ID: 14987534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychosocial factors predict CD4 and viral load change in men and women with human immunodeficiency virus in the era of highly active antiretroviral treatment.
    Ironson G; O'Cleirigh C; Fletcher MA; Laurenceau JP; Balbin E; Klimas N; Schneiderman N; Solomon G
    Psychosom Med; 2005; 67(6):1013-21. PubMed ID: 16314608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV and older adults: clinical outcomes in the era of HAART.
    Uphold CR; Maruenda J; Yarandi HN; Sleasman JW; Bender BS
    J Gerontol Nurs; 2004 Jul; 30(7):16-24; quiz 55-6. PubMed ID: 15287323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of transmission from HIV-infected individuals with HAART to their heterosexual serodiscordant partners.
    Del Romero J; Río I; Castilla J; Baza B; Paredes V; Vera M; Rodríguez C
    Enferm Infecc Microbiol Clin; 2015 Dec; 33(10):666-72. PubMed ID: 25555636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and clinical characteristics of HIV type 1-infected patients receiving dialysis in Spain: results of a Spanish survey in 2006: GESIDA 48/05 study.
    Trullàs JC; Barril G; Cofan F; Moreno A; Cases A; Fernandez-Lucas M; Martinez-Ara J; Ceballos M; Garcia-de-Diego J; Muñiz ML; Molina J; Martínez-Castelao A; González-Garcia J; Miró JM;
    AIDS Res Hum Retroviruses; 2008 Oct; 24(10):1229-35. PubMed ID: 18834322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delay in the initiation of HAART, poorer virological response, and higher mortality among HIV-infected injecting drug users in Spain.
    Rodríguez-Arenas MA; Jarrín I; del Amo J; Iribarren JA; Moreno S; Viciana P; Peña A; Sirvent JL; Vidal F; Lacruz J; Gutierrez F; Oteo JA; Asencio R; Castilla J; Hoyos SP;
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):715-23. PubMed ID: 16910826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
    Sterling TR; Chaisson RE; Moore RD
    AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary human immunodeficiency virus type 1 infection: clinical, virological and immunological characteristics of 75 patients (1997-2003).
    Sued O; Miró JM; Alquezar A; Claramonte X; García F; Plana M; Arnedo M; de Lazzari E; Gil C; Manzardo C; Blanco JL; Martínez E; Mallolas J; Joseph J; Pumarola T; Gallart T; Gatell JM
    Enferm Infecc Microbiol Clin; 2006 Apr; 24(4):238-44. PubMed ID: 16725083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is use of antiretroviral therapy among homosexual men associated with increased risk of transmission of HIV infection?
    Stephenson JM; Imrie J; Davis MM; Mercer C; Black S; Copas AJ; Hart GJ; Davidson OR; Williams IG
    Sex Transm Infect; 2003 Feb; 79(1):7-10. PubMed ID: 12576605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
    Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
    Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
    Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
    J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy.
    Núñez M; Asencio R; Valencia ME; Leal M; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2003 May; 19(5):363-8. PubMed ID: 12803995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the highly active antiretroviral therapy (HAART) era.
    Vilchez RA; Finch CJ; Jorgensen JL; Butel JS
    Medicine (Baltimore); 2003 Mar; 82(2):77-81. PubMed ID: 12640183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.